IDENTIFICATION OF A CUT-OFF FOR PERSISTENT ANTI-INFLIXIMAB ANTIBODIES AS A PREDICTOR OF RESPONSE TO INFLIXIMAB MONOTHERAPY

被引：0
|
作者：
Del Nero, L. [2 ]
Bodini, G. [2 ]
Giannini, E. G. [2 ]
Savarino, V [2 ]
De Maria, C. [2 ]
Baldissarro, I [2 ]
Savarino, E. [1 ]
机构：
[1] Univ Padua, Dept Surg Oncol & Gastroenterol, Gastroenterol Unit, Padua, Italy
[2] Univ Genoa, Dept Internal Med, Gastroenterol Unit, Genoa, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2016年 / 48卷
关键词：
D O I：
10.1016/S1590-8658(16)30027-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.02.6
引用
收藏
页码：E77 / E77
页数：1
相关论文
共 50 条
  • [41] ANTI-INFLIXIMAB ANTIBODIES: PREVALENCE, INFUSION REACTIONS, IMMUNOSUPPRESSION AND RESPONSE, A META-ANALYSIS
    Lee, L. Y.
    Sanderson, J.
    Irving, P.
    [J]. GUT, 2012, 61 : A226 - A226
  • [42] Clinical Laboratory Validation of a Functional Assay for Monitoring Infliximab Biological Activity and Neutralizing Anti-infliximab Antibodies
    Delgado, Julio
    Pavlov, Igor
    Kusukawa, Noriko
    Skodack, Lisa
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S517 - S518
  • [43] Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease
    Zitomersky, Naamah
    Chi, Lisa
    Liu, Enju
    Bray, Kurtis R.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Snapper, Scott B.
    Bousvaros, Athos
    Silvester, Jocelyn A.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (02): : 261 - 271
  • [44] Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn’s Disease Is Determined by Their Concentration
    Helena Edlund
    Casper Steenholdt
    Mark A. Ainsworth
    Eva Goebgen
    Jørn Brynskov
    Ole Ø. Thomsen
    Wilhelm Huisinga
    Charlotte Kloft
    [J]. The AAPS Journal, 2017, 19 : 223 - 233
  • [45] Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration
    Edlund, Helena
    Steenholdt, Casper
    Ainsworth, Mark A.
    Goebgen, Eva
    Brynskov, Jorn
    Thomsen, Ole O.
    Huisinga, Wilhelm
    Kloft, Charlotte
    [J]. AAPS JOURNAL, 2017, 19 (01): : 223 - 233
  • [46] THERAPEUTIC CUT-OFF OF INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Nagore, D.
    Ruiz del Agua, A.
    Pascual, J.
    Llinares-Tello, F.
    Herreros, B.
    Martinez, A.
    Martin, S.
    Navarro, R.
    [J]. GUT, 2015, 64 : A99 - A99
  • [47] Letter: detection of infliximab levels and anti-infliximab antibodies - comparison of three different assays; authors' reply
    Buurman, D. J.
    Vande Casteele, N.
    Sturkenboom, M. G. G.
    Kleibeuker, J. H.
    Vermeire, S.
    van der Kleij, D.
    Rispens, T.
    Gils, A.
    Dijkstra, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 282 - 282
  • [48] Detection of anti-infliximab antibodies is of limited value to predict acquired drug resistance to infliximab in rheumatoid arthritis
    Finckh, Axel
    Dudler, Jean
    Wennelinger, Felix
    Ciurca, Adrian
    Gabay, Cem
    Bas, Sylvette
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S777 - S777
  • [49] Neutralizing Effect of Anti-Infliximab Antibodies on Infliximab-Stimulated Human Coronary Artery Endothelial Cells
    Ogric, Manca
    Poljsak, Katjusa Mrak
    Lakota, Katja
    Zigon, Polona
    Praprotnik, Sonja
    Cucnik, Sasa
    Semrl, Snezna Sodin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [50] Comparison of three commercially available ELISA assays for anti-infliximab antibodies
    West, Timothy A.
    Sam, Melissa
    Toong, Catherine
    [J]. PATHOLOGY, 2020, 53 (04) : 508 - 514
12345